Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 3370
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT04447027 Romidepsin, CC-486 (5-azacitidine), Dexamethasone, and Lenalidomide (RA… |
Romidepsin | Cancer | Phase 1 | COMPLETED | En attente / non publié | National Cancer Institute (NCI) | United States · National Institutes of Health Clinica… | 2020-12-17 → 2025-12-17 | Ouvrir |
| NCT02769962 Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People Wi… |
EP0057 | Cancer | Phase 1 | TERMINATED | En attente / non publié | National Cancer Institute (NCI) | United States · National Institutes of Health Clinica… | 2016-05-09 → 2025-03-04 | Ouvrir |
| NCT07326566 Study of Silevertinib With Temozolomide for the Treatment of Newly Diag… |
silevertinib in combination with … | Cancer | Phase 2 | RECRUITING | En attente / non publié | Black Diamond Therapeutics, Inc. | United States · Atlantic Health, Summit, United State… | 2026-05-05 → 2029-03 | Ouvrir |
| NCT07763561 EUS-DFI in Solid Pancreatic Lesions |
EUS-DFI in Solid Pancreatic Lesio… | Cancer | À vérifier | NOT_YET_RECRUITING | En attente / non publié | Julio Iglesias García | Non communiqué | 2026-12-01 → 2027-12-31 | Ouvrir |
| NCT06692738 A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemoth… |
Rilvegostomig | Cancer | Phase 3 | RECRUITING | En attente / non publié | AstraZeneca | United States, Argentina, Australia, Austria, Belgium… | 2024-11-18 → 2030-07-01 | Ouvrir |
| NCT01445483 Neuropsychological Changes in Patients Receiving Radiation Therapy for … |
Neuropsychological Changes in Pat… | Cancer | À vérifier | COMPLETED | En attente / non publié | National Cancer Institute (NCI) | United States · National Institutes of Health Clinica… | 2009-04-17 | Ouvrir |
| NCT05722288 Time-Restricted Eating Versus Nutritional Counseling for the Reduction … |
Biospecimen Collection | Cancer | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | City of Hope Medical Center | United States · City of Hope Medical Center, Duarte, … | 2023-01-20 → 2027-07-05 | Ouvrir |
| NCT06007937 A Study of Lorlatinib in Combination With Ramucirumab in People With Lu… |
Lorlatinib | Cancer | Phase 1 | ACTIVE_NOT_RECRUITING | En attente / non publié | Chugai Pharmaceutical | United States · Memorial Sloan Kettering Bergen (All … | 2023-08-17 → 2028-08-17 | Ouvrir |
| NCT07763054 Low-dose Liposomal Amphotericin B for Antifungal Prophylaxis in Prolong… |
Liposomal Amphotericin B | Cancer | À vérifier | RECRUITING | En attente / non publié | Haikou Affiliated Hospital of Cen… | China · Haikou Affiliated Hospital of Central South U… | 2025-08-01 → 2026-11-30 | Ouvrir |
| NCT05219695 Medical Imaging and Focused Ultrasound Treatment for Breast Tumors Usin… |
Harmonic motion imaging guided fo… | Cancer | Phase 1 | RECRUITING | En attente / non publié | Columbia University | United States · Columbia University Irving Medical Ce… | 2022-01-19 → 2031-05 | Ouvrir |
| NCT06136650 A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hor… |
Opevesostat | Cancer | Phase 3 | RECRUITING | En attente / non publié | Merck Sharp & Dohme LLC | United States, Australia, Brazil, Canada, Chile, Chin… | 2023-12-18 → 2030-12-02 | Ouvrir |
| NCT00469339 Risk Communication Within Mexican-American Families |
Risk Communication Within Mexican… | Cancer | À vérifier | COMPLETED | En attente / non publié | National Human Genome Research In… | United States · MD Anderson Cancer Center, Houston, U… | 2007-04-27 | Ouvrir |
| NCT04170153 Tuvusertib (M1774) in Participants With Metastatic or Locally Advanced … |
M1774 | Cancer | Phase 1 | ACTIVE_NOT_RECRUITING | En attente / non publié | EMD Serono Research & Development… | United States, China, Japan, Spain, United Kingdom · … | 2019-12-20 → 2026-11-30 | Ouvrir |
| NCT07552558 Ficerafusp Alfa, Pembrolizumab, and Stereotactic Body Radiotherapy (SBR… |
Hypofractionated Stereotactic Bod… | Cancer | Phase 1 | NOT_YET_RECRUITING | En attente / non publié | Washington University School of M… | United States · Washington University School of Medic… | 2026-09-30 → 2033-11-30 | Ouvrir |
| NCT06614855 A Phase IB 2 Dose Trial of IRS-1 HSV C134 (IND 17296) Administered Intr… |
C134 | Cancer | Phase 1 | ACTIVE_NOT_RECRUITING | En attente / non publié | James Markert, MD | United States · The University of Alabama at Birmingh… | 2025-06-02 → 2028-01-01 | Ouvrir |
| NCT07593092 Phase 1, Safety and Tolerability Study of XmAb541 and XmAb808 in Advanc… |
XmAb541 | Cancer | Phase 1 | RECRUITING | En attente / non publié | Xencor, Inc. | United States · Xencor Investigative Site, Fort Worth… | 2026-06-30 → 2028-12 | Ouvrir |
| NCT07619534 Collection of CSF Samples From Participants With Metastatic Triple Nega… |
Collection of CSF Samples From Pa… | Cancer | À vérifier | NOT_YET_RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States · National Institutes of Health Clinica… | 2026-08-18 → 2034-07-01 | Ouvrir |
| NCT03181867 18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer |
18F-DCFPyL | Cancer | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States · National Institutes of Health Clinica… | 2017-08-03 → 2031-02-01 | Ouvrir |
| NCT00033137 Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Pre… |
Genetic Analysis of Birt Hogg-Dub… | Cancer | À vérifier | RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States · National Institutes of Health Clinica… | 2002-05-13 | Ouvrir |
| NCT07762703 Combination Immunotherapy Treatment for Locally Advanced Unresectable o… |
BreakVax | Cancer | Phase 1 | NOT_YET_RECRUITING | En attente / non publié | BreakBio Corp | United States · Miami Herbert Wertheim Cancer Institu… | 2026-09 → 2030-09 | Ouvrir |
| NCT06186401 Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-… |
E-SYNC T Cells | Cancer | Phase 1 | RECRUITING | En attente / non publié | Hideho Okada, MD, PhD | United States · University of California, San Francis… | 2024-04-30 → 2027-12-31 | Ouvrir |
| NCT05350475 Protons vs. Photons for High-risk Prostate Cancer |
Proton therapy | Cancer | Non applicable | ACTIVE_NOT_RECRUITING | En attente / non publié | University of Aarhus | Denmark · Department of Oncology, Aarhus University H… | 2022-03-01 → 2038-12-01 | Ouvrir |
| NCT07227077 Dosing Physical Activity Among Older Cancer Survivors Who Experience Ch… |
Dosing Physical Activity Among Ol… | Cancer | Non applicable | RECRUITING | En attente / non publié | Medical College of Wisconsin | United States · Froedtert Hospital, Milwaukee, United… | 2026-02-07 → 2027-08 | Ouvrir |
| NCT05873699 Study Using Hyperpolarized 13C-Pyruvate Magnetic Resonance Spectroscopi… |
Hyperpolarized 13-C-pyruvate | Cancer | Phase 1 | SUSPENDED | En attente / non publié | M.D. Anderson Cancer Center | United States · M D Anderson Cancer Center, Houston, … | 2023-08-18 → 2027-01-31 | Ouvrir |
| NCT04692675 Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Di… |
Multiparametric Magnetic Resonanc… | Cancer | Non applicable | RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States · National Institutes of Health Clinica… | 2022-11-18 → 2031-09-01 | Ouvrir |